Article

Investment volatility forces physicians to reexamine future plans

Physicians are evaluating what the stock market nosedive has done to their portfolios and plans. Physicians who are at or near retirement have been forced to reconsider whether to retire, keep working, or go back to work if they are already retired.

Related Videos
Ruben Olivares, MD, answers a question during a Zoom video interview
Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
Shot of a doctor showing a patient some information on a digital tablet | Image Credit | © bongkarn - stock.adobe.com
Related Content
Human Urinary System Kidneys with Bladder Anatomy | Image Credit: © magicmine - stock.adobe.com
June 13th 2025

CHAI biomarkers demonstrate prognostic utility for high-grade Ta NMIBC

Hannah Clarke
The CHAI biomarker was shown to outperform EAU and AUA stratifications.
Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
June 2nd 2025

Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP

Amy M. Pearlman, MD
3d rendered medically accurate illustration of prostate cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
June 13th 2025

64Cu-SAR-Bombesin shows efficacy in detecting prostate cancer recurrence

Hannah Clarke
The results from the SABRE trial are intended to support the design of a registrational trial of 64Cu-SAR-Bombesin.
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
May 17th 2025

Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD

Amy M. Pearlman, MD Alex Tatem, MD
Explore the latest insights on testosterone therapy, its benefits, and practical applications from leading urologists in men's health.
FDA approves mitomycin intravesical solution for recurrent LG-IR-NMIBC
June 12th 2025

FDA approves mitomycin intravesical solution for recurrent LG-IR-NMIBC

Hannah Clarke
The approval is supported by findings from the phase 3 ENVISION trial.
AI-based tool aims to optimize MRI use in prostate cancer diagnosis
June 12th 2025

AI-based tool aims to optimize MRI use in prostate cancer diagnosis

Madhur Nayan, MD, PhD
"I'm excited to see how these models are going to continue to be developed and applied in clinical practice, because precision medicine is here, and I’m looking forward to it," says Madhur Nayan, MD, PhD.
© 2025 MJH Life Sciences

All rights reserved.